EuGeni, page-2481

I couldn't help myself seeing some posts on Merck today. I have been going on about the possibility of a partnership b/w Merck and Anteotech for a while.

we had this in jan 21 quarterly

" we have recently commenced initial EuGeni overview with a leading German Clinic diagnostic company and we are entering into a CDA to enable further discussions."

Merck is a German clinic diagnostic company. the relationship between the 2 companies.

Madrid 2022 IVD conference Madrid March 24th 2022


https://www.sigmaaldrich.com/deepwe...4/299/ivd-conference-mar-2022-fl8801en-mk.pdf

Next generation summit 2021, Charlie spoke under Merck's banner


rapid point of care test development workshop may 3-5 2022

https://www.linkedin.com/posts/ante...tm_source=share&utm_medium=member_desktop

there has been plenty more over the years

we had this editorial article sponsored by Merck.

https://www.selectscience.net/edito...t-low-limit-sars-cov-2-detection/?artID=55136

The future of point of care

The combination of Estapor^® Europium Microspheres and AnteoBind™ has the potential to revolutionize point-of-care testing as this pioneering technology is designed to:

then in late dec 2021

Merck Announces €121 Million U.S. Government Contract Award for New Lateral Flow Membrane Production Facility in Sheboygan, Wisconsin, USA

https://www.sigmaaldrich.com/AU/en/collections/press/p131921544

been articles and interviews I have seen and heard that the facility will have 1billion membrane capacity and will offer services of manufacturing membranes (like operon did with us) or having a contract services to help develop the membrane test (like anteotech have)


then in the agm presentation




there is a fair bit more but I think the above sets a pretty strong picture.  

will the next ann be a life science partnership deal, battery partnership deal or government support. C'mon ADO !!!!!